Home

Konstantin Poukalov

CIK 1678736 · Executive Vice President, CFO · last filed 2024-06-14

Konstantin Poukalov is an Executive Vice President, CFO who has filed 13 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for LYRA, was dated Jun 14, 2024. Across all open-market trades the lifetime net is +$23.2M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

13

Lifetime Open-Market Net

$23.24M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LYRA Director — $0.70 — $0 5 2024-06-14
LianBio (LIAN) Delisted Director 36,300 $0.32 $11.6K $0 3 2024-02-20
Landos Biopharma, Inc. (LABP) Delisted Director 14,869,915 $22.93 $340.97M $23.21M 2 2021-02-09
Kadmon Holdings, Inc. (KDMN) Delisted Executive Vice President, CFO 3,000 $9.50 $28.5K $23.2K 3 2017-12-12

Recent Filings

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-14 LYRA Grant (A) — $0 EDGAR
2024-02-20 LianBio (LIAN) Delisted Mixed +17,082 -$2 EDGAR
2023-07-05 LYRA Grant (A) — $0 EDGAR
2023-06-23 LianBio (LIAN) Delisted Grant (A) — $0 EDGAR
2022-06-27 LianBio (LIAN) Delisted Grant (A) — $0 EDGAR
2022-06-21 LYRA Grant (A) — $0 EDGAR
2021-05-28 LYRA Grant (A) — $0 EDGAR
2021-02-09 Landos Biopharma, Inc. (LABP) Delisted Buy (P) +250,187 $3.21M EDGAR
2021-02-08 Landos Biopharma, Inc. (LABP) Delisted Mixed +14,619,728 $20.00M EDGAR
2020-05-01 LYRA Grant (A) — $0 EDGAR
Showing 1–10 of 13
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.